Authors
Latest:
New Frontiers in Technology: AI Use in Clinical Trial Patient Recruitment in Health SystemsAI is significantly enhancing the efficiency of identifying and enrolling patients.
Latest:
Long Story Short: Cellulitis Can Be Treated in Less Than a WeekDuration of therapy may be just 5 to 6 days for patients without risk factors for complications.
Latest:
HER2 and HER3 in NSCLC: The Latest ADC Data and NCCN Guideline UpdatesCorrine Stahura, PharmD, and Sophia Gilardone, PharmD, BCOP, discuss recent clinical trial data and evolving guideline recommendations for HER2- and HER3-directed antibody-drug conjugates (ADCs) in non–small cell lung cancer (NSCLC), highlighting differences in efficacy, safety, and patient selection criteria.
Latest:
One Year Later: Key Issues Impacting Health System Pharmacies During the COVID-19 Vaccine RolloutThis vaccine rollout has become even more crucial for the US health care system, as new mutations of the coronavirus continue to emerge.
Latest:
Student Advocacy in PharmacyStudent pharmacists can work toward a better future for patients, themselves, and the profession.
Latest:
Fellowship Focus: Elevating Pediatric Medication Safety Through Data, AI, and CollaborationOchsner Children’s Hospital, in partnership with ISMP, has launched a fellowship to advance pediatric medication safety through hands-on training in key competencies, national safety strategies, interdisciplinary collaboration, and innovative tools such as AI and data dashboards.
Latest:
Inside the Legislative Battle Over Oncology Patients’ Access to Critical MedicationsLegislative efforts aim to improve oncology medication access, addressing transportation barriers and advocating for mail delivery from cancer clinics.
Latest:
Updated Clinical Guidelines Outline Optimal Treatment of Helicobacter pylori InfectionFor pharmacists wondering whether bismuth quadruple therapy still reigns as the gold standard, the wait is over—the latest recommendations are here.
Latest:
How Data Can Help Demonstrate the Value of the Health-System Specialty PharmacyInsurers, accountable care organizations, and manufacturers increasingly look for demonstrable clinical outcomes as proof for reimbursement or access to limited distribution networks.
Latest:
As Shortages Continue, Suppliers, Hospitals, and Health Systems Look for New SolutionsHospitals, health systems, and the supply chain are all negatively impacted by drug shortages and are each affected by the decisions of the others.
Latest:
Asembia AXS25: Digital Pharmacy Strategies for Patient-Centered CareDigital pharmacy solutions are revolutionizing patient care.
Latest:
Commonly Overlooked Adverse Effects in the Community, Clinical Pharmacy SettingsAlthough pharmacists possess a wealth of knowledge on AEs, it remains a monumental task to recall the clinical significance of every AE, even with the most commonly used medications.
Latest:
Integration of Palliative Pharmacists to Elevate Oncologic CarePalliative pharmacists are invaluable assets of oncologic care.
Latest:
Managing Sustainable Drug Spend: 5 Trends Reshaping Pharmacy Benefits in 2025The US health care market faces transformative changes in 2025, as biosimilars, GLP-1s, and new pharmacy economics reshape how benefit managers balance innovation with affordability.
Latest:
Precision Oncology in Focus: ctDNA's Role in Colon Cancer ManagementSasha Watson, PharmD, BCOP, discusses the emerging role of circulating tumor DNA (ctDNA) in colon cancer, highlighting its potential to enhance precision oncology by improving early detection, guiding adjuvant therapy decisions, and monitoring disease recurrence and treatment resistance.
Latest:
Managing Tardive Dyskinesia With VMAT2 Inhibitors in Clinical PracticeVMAT2 inhibitors can improve movement symptoms.
Latest:
Interaction Considerations for Common OTC Drug ClassesAlthough OTC medications are generally considered safe when used as directed, there are some key drug interactions for pharmacists to keep in mind when helping patients choose an OTC product.
Latest:
Pharmacists Have a Significant Role in the Prevention of Travel-Related DiseasesWhen helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Latest:
AHA Statement Reviews Benefits, Risks of Alternative Therapies for Heart FailureThe AHA acknowledged that complementary and alternative medicines are widely used by heart failure patients but warned that there is limited scientific evidence to support their efficacy.
Latest:
Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWDThis abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.
Latest:
Balancing Pharmaceutical Reimbursement and Market Access With the Right PartnerManufacturers must find the right balance in drug pricing, so that medications are appealing to both public and private insurers while still remaining profitable throughout their lifecycle.
Latest:
Case Study: New Treatment Options for Patients With Chronic Lymphocytic LeukemiaWith a better understanding of the underlying pathophysiology of chronic lymphocytic leukemia and the introduction of novel targeted agents, such as Bruton kinase Inhibitors, the prognosis of high-risk patients has changed dramatically.
Latest:
Vax-Innovation: Incorporating the Newly Approved RSV and Pneumococcal Vaccines Into Community Pharmacy WorkflowBest practices to train staff and team members to engage patients and to ease the new vaccine offerings into the workflow are also discussed.
Latest:
St. John’s Wort Could Show Benefit in Major Depressive DisorderPatients with MDD may also seek complementary or alternative therapies in the form of dietary supplements which might be perceived by patients to be natural and safer than medicinal agents.
Latest:
Comparative Oncology: Advances in Cancer Care from Pets to HumansDogs share a number of cancers with humans, including melanoma, non-Hodgkin lymphoma, leukemia, and osteosarcoma.
Latest:
Understand Effective Strategies for Monitoring Topical Dermatological AgentsMatthew Zirwas, MD, highlights the discrepancy between perceived and actual usage, citing studies that reveal patients often overestimate their compliance.
Latest:
Pharmacy’s Role in Treating Rare Disease: Connecting Patients, Providers, Payers, and PharmaPharmacy's position at the intersection of the care team gives it a unique ability to connect providers, payers, and pharmaceutical manufacturers, and support patients to maximize their health outcomes.
Latest:
The Blood Detective: Tackling Medication-Induced Hematological DisordersThese disorders can be fatal, making pharmacists’ role in detection crucial.
Latest:
Advances in the Management of HR+/HER2– Ultralow and -Low Metastatic Breast Cancer: New Horizons and Treatment FrontiersAntibody-drug conjugates have revolutionized metastatic breast cancer treatment and classification.
